de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
'Functional unblinding was a major barrier to the approval of psychedelics as medicines to treat the patients who need them most,' said Dr. Andrew Chadeayne, CaaMTech CEO. 'I'm incredibly proud that ...
To be haunted, “One need not be a House,” wrote the great poet Emily Dickinson in 1862, “The Brain—has Corridors surpassing ...
A̅repa is conducting further research on how a novel molecule discovered from New Zealand blackcurrants, which it has also ...
One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building ...
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are two of the most common types of medications used to treat conditions such as depression, ...
Now, in a study published in Science Signaling, a team of scientists revealed how one molecule produced in the gut, the neurotransmitter serotonin, activates a subset of T cells and dampens the immune ...
Drug interaction with hERG can elicit fatal cardiac arrhythmias, while off-target activation of the serotonin receptor ... of novel neuroplastogenic small-molecule therapeutics for the treatment ...
The Department of Chemistry and Molecular Biology conducts high-quality research and education in the areas of chemical sciences and molecular life sciences. Our research and education focus on a deep ...